Skip to main content

Table 2 Patient overview with details about treatment, tumour location and bone resection

From: Clinical validation of a commercially available deep learning software for synthetic CT generation for brain

Patient

Glioma (G)/metastasis (M)

Prescribed dose [Gy]

Beam configuration

PTVvol [cc]

Bone resected (yes/no)

Max d* [mm]

Tumour location

1

M

25.0

2 arcs

31

N

–

Right thalamus

2

G

34.0

2 arcs, NC

408

Y

10

Right frontal/temporal

3

M

30.0

1 arc

5

Y

10

Left frontal

4

M

30.0

3 arcs, NC

10

Y**

10

Right occipital

5

G

40.05

1 arc

181

Y

10

Left frontal/parietal

6

G

40.05

2 arcs

448

Y

10

Right temporal

7

G

40.05

2 half arcs

186

Y

10

Left occipital/temporal

8***

M

30.0

2 arcs

21

Y

20

Cerebellum

9

M

30.0

1 arc

41

N

–

Right frontal

10***

M

30.0

2 arcs

2

N

–

Left occipital

11

G

60.0

4 arcs, NC

439

Y

10

Bilateral frontal/temporal

12

G

34.0

2 half arcs

314

Y

10

Left frontal/temporal

13

M

24.0

2 arcs

63

N

–

Left temporal

14

G

60.0

2 arcs

179

Y

10

Left frontal/temporal

15

G

60.0

2 half arcs

168

Y

10

Left temporal/occipital

16***

G

60.0

2 arcs, NC

430

Y

30

Left hemisphere

17

M

30.0

2 arcs

16

N

–

Left parietal

18

G

25.0

2 arcs

318

Y

10

Left hemisphere

19

M

30.0

2 arcs, NC

21

Y**

10

Right occipital

20

M

30.0

3 arcs, NC

25

N

-

Right parietal

  1. Patients identified as having targets in complex regions were number 2, 6, 8, 11, 14, 16 and 18
  2. *Max d refers to the maximum diameter of the bone resection. One patient may have more than one resection area, in which case the largest one is presented
  3. **Bone resection from previous surgery, not adjacent to the PTV evaluated in this study
  4. ***Three of the patients are presented in Fig. 1 to represent the range of tumour locations and sizes; patient 10 corresponds to patient A, patient 8 corresponds to patient B and patient 16 corresponds to patient C